4.6 Review

The Effects of Drugs used for the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) on Pregnancy Outcome and Breast-feeding: A Critical Review

期刊

CURRENT NEUROPHARMACOLOGY
卷 19, 期 11, 页码 1794-1804

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1570159X18666201127164000

关键词

ADHD; pregnancy outcome; drugs; stimulants; complications of pregnancy; non-stimulant drugs; lactation

向作者/读者索取更多资源

ADHD is a neurobehavioral condition affecting 5-10% of school-age children and 2-5% of adults. Stimulant medications like methylphenidate and amphetamines may have potential risks in pregnancy, while bupropion as an antidepressant seems to be safer. Limited data is available on the effects of ADHD medications on pregnancy and long-term neurodevelopment in children.
Attention deficit/hyperactivity disorder (ADHD) is a neurobehavioral condition found in 5-10% of school-age children and in 2-5% of adults. Stimulants affecting the dopaminergic, noradrenergic and/or serotonergic systems are commonly used for treatment in children and adults, including women of childbearing age. The data on the effects of stimulants (methylphenidate and amphetamines) in pregnancy are generally reassuring, but methylphenidate might slightly increase the rate of cardiac malformations and of spontaneous abortions, while amphetamines might slightly increase the risk for premature birth, low birth weight and other pregnancy complications. Bupropion, a dopamine and norepinephrine reuptake inhibitor, when used as an antidepressant, appears to be safe in pregnancy. The data on the use of atomoxetine, guanfacine and clonidine in pregnancy are scarce. Importantly, there are practically no data on the long-term neurodevelopmental effects of most of these drugs. The published data on the development of children born to met hamphetamineabusing women may be misleading since these women generally use other drugs, including alcohol, and the home environment where the child is raised may not be optimal. The treating physician should judge the need for treatment during pregnancy in relation to the severity of the clinical symptoms. If needed, methylphenidate is preferred over amphetamines because breast feeding is possible. If one uses non-stimulant medications, bupropion seems to be the preferred drug.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据